首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1496879

全球椎体成形术和椎体后凸成形术市场 - 2024-2031

Global Vertebroplasty and Kyphoplasty Market - 2024-2031

出版日期: 2024年06月18日 | 出版商:

DataM Intelligence | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

司机

骨质疏鬆症和脊椎疾病的发生率上升

全球椎体成形术和椎体后凸成形术市场的需求是由多种因素所驱动的。骨质疏鬆症是美国普遍存在的公共卫生问题。美国卫生局局长最近向美国人介绍了骨质疏鬆症的重要性，广泛的研究表明，椎体压迫性骨折是骨质疏鬆症最常见的併发症之一。

白人女性终生罹患骨质疏鬆性脊椎骨折的风险为 15.6%。美国每年诊断出超过 70 万起继发于骨质疏鬆症的椎体骨折，导致 11.5 万人入院治疗。骨质疏鬆性压迫性骨折的主要后果是背痛、脊椎后凸和身高下降。

此外，该行业的主要参与者推出新产品和技术将推动该市场的成长。例如，2023 年 10 月，荷兰公司 Amber Implants 开始开发用于脊椎损伤的下一代植入物，开始对其 VCFix 脊椎系统进行临床试验。该植入物旨在透过椎弓根锚定来优化脊椎中的负荷分布。

首次人体试验将评估 VCFix 对椎骨压迫性骨折患者的安全性和有效性。它还包含一次性无菌手术套件，以确保可追溯性并降低感染风险。

此外，2021年8月，IZI Medical正式推出Vertefix HV Cement，该产品旨在解决椎体成形术和椎体后凸成形术中水泥注射过程中即时流量可视化的需求。

限制

与治疗相关的高成本、严格的监管框架、与手术相关的併发症、缺乏熟练的专业人员以及有限的报销政策等因素预计将阻碍市场。

有关此报告的更多详细资讯 - 索取样品

Kyphoplasty differs from vertebroplasty in that a balloon is first inflated in the vertebral body to create a cavity into which cement is then injected under lower pressure. Kyphosis is a modern spine surgery procedure used to stabilize vertebral compression fractures caused by osteoporosis, cancer, and other conditions.

The market is driven by factors such as a rise in the adoption of minimally invasive surgeries, a rising incidence of osteoporosis & spinal disorders, an increase in the geriatric population, a rise in accidental cases, and technological advancements in healthcare.

Market Dynamics

Drivers

Rising Incidence of Osteoporosis & Spinal Disorders

The demand for the global vertebroplasty and kyphoplasty market is driven by multiple factors. Osteoporosis is a widespread public health problem in the United States. The surgeon general of the United States has recently introduced special attention to the importance of osteoporosis to Americans extensive study states that vertebral body compression fractures are among the most common complications of osteoporosis.

The lifetime risk of osteoporotic spine fracture in white women is 15.6%. Each year, more than 700,000 vertebral body fractures secondary to osteoporosis are diagnosed in the United States, resulting in 115,000 hospital admissions. The major consequences of osteoporotic compression fractures are back pain, kyphosis, and height loss.

Moreover, major key players in the industry launching new products and technology would propel this market growth. For instance, in October 2023, Amber Implants, a Netherlands-based company developing next-gen implants for spinal injuries, began clinical trials for its VCFix spinal system. The implant seeks to optimize load distribution in the spine via pedicle anchorage.

The first-in-human trial will evaluate VCFix's safety and efficacy for patients with vertebral compression fractures. It's also included with a single-use, sterile surgical kit to ensure traceability and reduce infection risk.

Also, in August 2021, IZI Medical officially launched Vertefix HV Cement, a product which aims to address the need for real-time flow visualization during cement injection for vertebroplasty and kyphoplasty procedures.

Restraints

Factors such as the high cost associated with the treatment, stringent regulatory framework, complications associated with the procedures, lack of skilled professionals, and limited reimbursement policies are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global vertebroplasty and kyphoplasty market is segmented based on device type, application, end-user, and region.

The kyphoplasty device segment accounted for approximately 62.5% of the global vertebroplasty and kyphoplasty market share

The kyphoplasty segment is expected to hold the largest market share over the forecast period owing to the advantages that kyphoplasty provides over vertebroplasty, such as reduction in back pain, as well as restoration of vertebral body height, and a lower rate of cement extravasation. This is mainly done by placing balloons to gently elevate the fractured vertebrae in an attempt to return them to the correct position.

According to the study published in Frontiers in Surgery Journal in July 2022, the use of kyphoplasty for the clinical treatment of osteoporotic vertebral compression fractures, spinal metastatic tumors, hemangiomas, myelomas, and vertebral nonunion has increased with the global development of minimally invasive spinal surgery.

Therefore, the rising adoption of kyphoplasty procedures for the treatment of vertebral compression fractures and cancers will lead to increased adoption of kyphoplasty devices, expected to drive the segment's growth.

Geographical Analysis

North America accounted for approximately 42.3% of the global vertebroplasty and kyphoplasty market share

North America region is expected to hold the largest market share over the forecast period owing to factors such as better healthcare infrastructure, rising funding from the government, awareness among people and healthcare industry stakeholders about available technologies, and the high concentration of market players in the region.

For instance, in September 2022, RevBio was awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health. With the help of this grant, the company will be able to develop Tetranite, a patented bone adhesive technology, for the treatment of vertebral compression fractures.

Therefore, such funding for the development of technologies in vertebral compression fractures is expected to drive market growth due to the increased launch and adoption of products in the market over the forecast period.

Furthermore, according to Osteoporosis Canada, 2022, more than 2.3 million Canadians are living with osteoporosis and at least 1 in 3 women and 1 in 5 men suffer from an osteoporotic fracture during their lifetime. Such a huge prevalence of osteoporosis in Canada is expected to increase the adoption of vertebroplasty and kyphoplasty procedures in the Canadian population, thereby leading to the rising adoption of vertebroplasty and kyphoplasty devices, driving the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global vertebroplasty and kyphoplasty market. Hospital admissions for patients other than COVID-19 and serious diseases were restricted to hospitals to avoid the spread of the virus.

For instance, according to the study published in SAGE Journals in April 2022, there have been noticeable changes in the hospital admissions of patients with vertebral compression fractures (VCF) compared to the period before the COVID-19 pandemic. Fewer patients visited the emergency department for VCF during the peak of the Covid-19 pandemic which represented a 44% decrease. Hence, COVID-19 affected the pace of the market at the beginning of the pandemic.

Market Segmentation

By Device Type

Vertebroplasty Device
- Needle
- Cement Mixing & Delivery Devices
- X-ray Device
Kyphoplasty Device
- Needle
- Balloon
- X-ray Device

By Application

Traumatic Vertebral Fractures
Osteoporotic Vertebral Fractures

By End-User

Hospitals
Ambulatory Surgical Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the vertebroplasty and kyphoplasty market include Medtronic, Jayon Implants, Johnson & Johnson, Joimax, Teknimed, Globus Medical, Stryker, MEDAID Inc, Biopsybell, and Merit Medical Systems among others.

Key Developments

In August 2023, Safe Orthopaedics SAS reported results from a biomechanical study comparing its new surgical technique Sycamore a pedicle-anchored implant with standalone balloon kyphoplasty.
In October 2022, Halma announced the acquisition of IZI Medical Products, a leading designer, manufacturer, and distributor of medical devices used across a range of diagnostic and therapeutic procedures. IZI Medical Products offers vertebroplasty and kyphoplasty products such as DURO-JECT Bone Cement Injector Set, Vertefix HV High Viscosity Bone Cement, and Kiva VCF Treatment System, which further expands Halma's product portfolio.
In April 2022, Nanox announced FDA approval for HealthOST Device, an AI software monitoring vertebral compression fractures and low bone density, which are frequently associated with osteoporosis.
In February 2022, Enlife Solutions represented Tecres, an Italian company in Romania. The representation includes a spinal and cranial portfolio of Tecres, including a Mendec spine vertebroplasty kit for osteoporosis.

Why Purchase the Report?

To visualize the global vertebroplasty and kyphoplasty market segmentation based on device type, application, end-user, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of global vertebroplasty and kyphoplasty market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in excel consisting of key products of all the major players.

The global vertebroplasty and kyphoplasty market report would provide approximately 62 tables, 55 figures, and 182 Pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Device Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Incidence of Osteoporosis & Spinal Disorders
  - 4.1.1.2. Rise in the Adoption of Minimally Invasive Surgeries
  - 4.1.1.3. Increase in the Geriatric Population
  - 4.1.1.4. Technological Advancements in Healthcare
- 4.1.2. Restraints
  - 4.1.2.1. High Cost Associated with the Treatment
  - 4.1.2.2. Lack of Skilled Professionals
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Device Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 7.1.2. Market Attractiveness Index, By Device Type
7.2. Vertebroplasty Device*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.2.3. Needle
- 7.2.4. Cement Mixing & Delivery Devices
- 7.2.5. X-ray Device
7.3. Kyphoplasty Device
- 7.3.1. Needle
- 7.3.2. Balloon
- 7.3.3. X-ray Device

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Traumatic Vertebral Fractures *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Osteoporotic Vertebral Fractures

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Specialty Clinics

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. South Korea
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Medtronic *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio & Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Jayon Implants
12.3. Johnson & Johnson
12.4. Joimax
12.5. Teknimed
12.6. Globus Medical
12.7. Stryker
12.8. MEDAID Inc
12.9. Biopsybell
12.10. Merit Medical Systems

LIST NOT EXHAUSTIVE

13. Appendix

13.1. About Us and Services
13.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球椎体成形术和椎体后凸成形术市场 - 2024-2031

Global Vertebroplasty and Kyphoplasty Market - 2024-2031

市场动态

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：COVID-19 分析

第 7 章：按装置类型

第 8 章：按申请

第 9 章：最终用户

第 10 章：按地区

第 11 章：竞争格局

第 12 章：公司简介

第 13 章：附录